Related Experiment Video
Updated: Mar 9, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
The fifth epidermal growth factor like region of thrombomodulin alleviates LPS-induced sepsis through interacting
Bin Pan, Xiangmin Wang, Shinsuke Kojima
1Kailin Xu, MD, Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, #99 West Huaihai Road, Xuzhou 221002, China, Tel.: +86 516 8580 2382, Fax: +86 516 8560 1527,
Abstract:
Thrombomodulin (TM) exerts cytoprotection via the fifth region of epidermal growth factor (EGF)-like domain of TM (TME5) by interacting with G-protein coupled receptor 15 (GPR15) expressed on cell surface of vascular endothelial cells. TM is also implied to mediate anti-inflammatory functions by unknown mechanism. By applying a lipopolysaccharide (LPS)-induced murine sepsis model, we assessed the role of TME5 in septic inflammation and coagulation. We found that TME5 treatment protected mice in association with ameliorating inflammation and coagulopathy in LPS-induced sepsis. Further study confirmed that TME5 bound GPR15 in vitro. Knock out of GPR15 abolished protective role of TME5 in sepsis model. GPR15 mediated anti-inflammatory function of TME5 through suppression of phosphorylation of IκBα, nuclear translocation of NF-κB and release of pro-inflammatory cytokines in macrophages (Macs). Knock out of GPR15 resulted in dysregulated immune response of Macs, characterised by excessive expression of pro-inflammatory genes and failing to limit immune response. This study indicates that TME5 exerts anti-inflammatory function through inhibition of NF-κB in a GPR15-dependent manner. The use of TME5 may be a potential therapeutic option for treatment of sepsis.
Insights
Thrombomodulin
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Thrombomodulin (TM) has known cytoprotective effects via its TME5 domain, interacting with GPR15 on vascular endothelial cells.
- The anti-inflammatory mechanisms of TM remain largely unknown.
- Sepsis involves complex inflammation and coagulation dysregulation.
Purpose of the Study:
- To investigate the role of TME5 in modulating inflammation and coagulation during sepsis.
- To elucidate the mechanism by which TME5 exerts anti-inflammatory effects.
Main Methods:
- Utilized a lipopolysaccharide (LPS)-induced murine sepsis model.
- Assessed the effects of TME5 treatment on sepsis outcomes, inflammation, and coagulation.
- Confirmed TME5-GPR15 interaction in vitro and evaluated the impact of GPR15 knockout.
Main Results:
- TME5 treatment ameliorated inflammation and coagulopathy in LPS-induced sepsis.
- TME5 directly binds to GPR15, and GPR15 knockout abrogated TME5's protective effects.
- GPR15 mediated TME5's anti-inflammatory action by suppressing NF-κB signaling in macrophages.
Conclusions:
- TME5 exerts anti-inflammatory effects in sepsis through GPR15-dependent inhibition of NF-κB signaling.
- GPR15 knockout leads to dysregulated macrophage immune responses.
- TME5 represents a potential therapeutic strategy for sepsis treatment.
Related Concept Videos
GPCR Desensitization
Formation of Lipopolysaccharides
Intracellular Signaling Affects Focal Adhesions
Some...

